Axitinib
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1994 publications
Endothelial cell-derived VEGF-A signaling initiated during oxygen-glucose deprivation promotes proliferation after reoxygenation.
Journal: Biochemical and biophysical research communications
Published: October 19, 2026
Clinical analysis of 21 children with Xp11.2 translocation renal cell carcinoma
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: October 15, 2026
Investigating Real-World Tolerance and Dose Reductions of Oncology Multikinase Inhibitors in a VA Population.
Journal: Federal practitioner : for the health care professionals of the VA, DoD, and PHS
Published: September 09, 2026
Local control of RCC pancreatic metastases is obtained by angiogenesis inhibitors.
Journal: Acta clinica Belgica
Published: September 03, 2026
The Transition From Sunitinib Monotherapy to Modern First-Line Tyrosine Kinase Inhibitor (TKI)-Containing Regimens in Metastatic Clear-Cell Renal Cell Carcinoma.
Journal: Cureus
Published: August 31, 2026
Integrated single-cell and bulk RNA-Seq analysis reveals a LCR-related prognostic signature for precision prognostication and therapeutic stratification in clear cell renal cell carcinoma.
Journal: Cancer treatment and research communications
Published: August 26, 2026
Cost‑effectiveness of first‑line immunotherapy-based combination regimens for advanced renal cell carcinoma in China and the United States.
Journal: Human vaccines & immunotherapeutics
Published: August 22, 2026
Comparative Evaluation of the Effectiveness of Nivolumab Versus Axitinib in the Second-Line Treatment of Patients with Metastatic Renal Cell Carcinoma: A Two-Center Experience.
Journal: Journal of clinical medicine
Published: August 21, 2026
Renal injury phenotypes with ICI-VEGFR-TKI combinations in renal cell carcinoma: active-comparator analyses in FAERS and JADER.
Journal: Frontiers in immunology
Published: August 18, 2026
Composite Inflammatory Score for Predicting Progression-Free Survival in Metastatic Clear Cell Renal Cell Carcinoma Treated With First-Line Toripalimab Plus Axitinib.
Journal: The Kaohsiung journal of medical sciences
Published: August 17, 2026
Repurposed Axitinib delivered via lipid-extruded PEGylated liposomes: 2D/3D breast cancer cell evaluation and in-vivo pharmacokinetics.
Journal: Journal of liposome research
Published: August 06, 2026
Gomisin A Attenuates Cerebral Ischemia/Reperfusion Injury Through Activation of the VEGF/PI3K/AKT/NOS3 Signaling Pathway.
Journal: Cell biochemistry and biophysics
Published: July 31, 2026
Last Updated: 11/08/2026